Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3624 Clinical outcomes of everolimus (EVE) for patients with advanced rectal neuroendocrine tumors (ARNETs) – A single-institutional retrospective study

Introduction: RADIANT-4 has established EVE as one of the standard-of-care for advanced NET G1–2 of gastrointestinal or lung origin, with a trend of a poorer efficacy of EVE in ARNET (median progression-free survival [PFS] of EVE: 17.3 months in advanced midgut NETs vs 7.4 months in the ARNETs). Little is known about the clinical outcomes of EVE for ARNET G1–2 and G3 in the real-world setting.

Conference:

Presenting Author: Kim Y

Authors: Kim Y, Hirano H, Yamamoto S, Okita N, Shoji H,

Keywords: everolimus, rectal neuroendocrine tumor,